Atlas Trials

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Clinical trial NCT02651220 · COMPLETED

Trial details

NCT number
NCT02651220
Sponsor
Actavis Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne
Start date
2015-11-01
Primary completion
2016-04-01
Enrollment
1001

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.